Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
testosterone/neoplasms
Le lien est enregistré dans le presse-papiers
Page 1 de 41 résultats
Prophylactic perioperative testosterone supplementation for protection of and recovery of function
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
U.S. GOVERNMENT SUPPORT
Not applicable.
BACKGROUND OF THE INVENTION
1. Area of the Background
This invention is generally in the area of urology and more specifically in improved treatment and outcome for radical prostatectomy surgery.
2. Description of the Background
Low testosterone level
Pharmaceutical compositions containing testosterone and an aromatase inhibitor
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
Testosterone, delivered by subcutaneous pellet implant has been used in the United States, Europe and Australia in both men and women to treat symptoms of testosterone deficiency. Symptoms of testosterone hormone deficiency include fatigue, lack of energy, depression, memory loss,
Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
A. Field of the Invention
The invention relates to the use of nutrient combinations to prevent or reduce potential adverse effects from administration of androgenic testosterone precursors to humans and other mammals Specifically, the invention relates to
Methods for decreasing steroidogenesis in prostate cancer cells
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
The present invention relates in general to compositions and methods for treatment of cancer. More specifically, the invention provides compositions and methods for treating diseases such as cancer by disrupting the luteinizing hormone (LH)/luteinizing hormone receptor (LHR)
Method of treating prostate cancer with GnRH antagonist
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Prostate cancer is a leading cause of morbidity and mortality for men in the industrialized world. The American Cancer Society estimates that during 2007 about 218,890 new cases of prostate cancer will have been diagnosed in the United States alone. Prostate cancer is the second leading cause of
Method of treating prostate cancer with GnRH antagonist
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Prostate cancer is a leading cause of morbidity and mortality for men in the industrialized world. The American Cancer Society estimates that during 2007 about 218,890 new cases of prostate cancer will have been diagnosed in the United States alone. Prostate cancer is the second leading cause of
Method of treating prostate cancer with GnRH antagonist
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Prostate cancer is a leading cause of morbidity and mortality for men in the industrialized world. The American Cancer Society estimates that during 2007 about 218,890 new cases of prostate cancer will have been diagnosed in the United States alone. Prostate cancer is the second leading cause of
Indole derivatives useful as testosterone 5.alpha.-reductase inhibitors
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application is a National Stage application of PCT/JP94/00406, filed Mar. 14, 1994, which published as WO94/22821 on Oct. 13, 1994.
TECHNICAL FIELD
The present invention relates to novel indole derivatives and pharmaceutically acceptable salts thereof. More particularly, it relates to novel
Inhibitors for testosterone 5.alpha.-reductase activity
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This invention relates to pharmaceutical compositions and methods for the treatment of androgen-related diseases, said compositions having novel inhibitors of testosterone 5.alpha.-reductase activity. The inhibitors have a good combination of inhibitory effect on
Testosterone compounds and use for the protection of neurons
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
TECHNICAL FIELD
The present invention relates to novel methods for conferring neuroprotection on a subject that relies on administering an effective dose of at least one testosterone inhibitor.
BACKGROUND TO THE INVENTION
Neurodegenerative diseases have a major impact on society. For example,
Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
Prostate cancer is the most commonly diagnosed cancer in American men and the second most common cause of death from cancer in American men.
Androgen withdrawal, by castration or through the use of an anti-androgenic drug, is the preferred treatment method for prostate
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This application relates to a method and compositions for chemosensitization and radiosensitization of cancer cells through administration of compositions, such as antisense oligonucleotides, which reduce the amount of TRPM-2 in the cells. The invention is of particular
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This application relates to a method and compositions for chemosensitization and radiosensitization of cancer cells through administration of compositions, such as antisense oligonucleotides, which reduce the amount of TRPM-2 in the cells. The invention is of particular
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This application relates to a method and compositions for chemosensitization and radiosensitization of cancer cells through administration of compositions, such as antisense oligonucleotides, which reduce the amount of TRPM-2 in the cells. The invention is of particular
Anti-aromatase pharmaceutical composition for controlling testosterone/estrone ratios
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
It is known, that throughout life of a mammal or a human being, testosterone/estrone ratios do have a considerable effect on mammal or human life.
This testosterone/estrone ratio will exert a powerful and considerable reactions to the emotional well being, as well as in sexual functions, libido,
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
